Search

Author/Creator Leavitt, Blair

1. 241  Intrathecal antisense oligonucleotide delivery in HD: experience from RG6042 programme and best practice considerations. Issue 6 (27th May 2022)

Authors:
Leavitt, Blair; Wild, Edward; Bang, Jee; Smith, Anne; Schlegel, Valerie; Schobel, Scott; Nicotra, Alessia; Landwehrmeyer, Bernhard; Tabrizi, Sarah
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 93:Issue 6(2022)
Page Start:
A83
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. E02 Standardising and observing atrophy and cognitive patterns across the lifetime of Huntington's disease using data from the HD-YAS and TRACK-HD and TrackOn-HD studies. (12th September 2022)

Authors:
Field, Sophie; Durr, Alexandra; Roos, Raymund AC; Leavitt, Blair; Tabrizi, Sarah J; Scahill, Rachael I
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 93(2022)Supplement 1
Page Start:
A28
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. F21 Cag-dependent huntington's disease patterns over decades: the track-hd and track-on studies. (September 2018)

Authors:
Langbehn, Douglas; Scahill, Rachael; Mills, James; Durr, Alexandra; Leavitt, Blair; Roos, Raymund; Long, Jeffrey; Gregory, Sarah; Owen, Gail; Johnson, Hans; Borowsky, Beth; Craufurd, David; Reilmann, Ralf; Stout, Julie C; Landwehrmeyer, Bernhard; Tabrizi, Sarah J
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 89(2018)Supplement 1
Page Start:
A47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. J01 Effects of IONIS-HTTRX (RG6042) in patients with early huntington's disease, results of the first htt-lowering drug trial. (September 2018)

Authors:
Tabrizi, Sarah J; Leavitt, Blair; Landwehrmeyer, Bernhard; Wild, Edward; Saft, Carsten; Barker, Roger; Craufurd, David; Rickards, Hugh; Rosser, Anne; Priller, Josef; Kordasiewicz, Holly; Czech, Christian; Swayze, Eric; Norris, Daniel A; Baumann, Tiffany; Gerlach, Irene; Schobel, Scott; Smith, Ann...
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 89(2018)Supplement 1
Page Start:
A97
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Natural biological variation of white matter microstructure is accentuated in Huntington's disease. Issue 9 (22nd April 2018)

Authors:
Gregory, Sarah; Crawford, Helen; Seunarine, Kiran; Leavitt, Blair; Durr, Alexandra; Roos, Raymund A. C.; Scahill, Rachael I.; Tabrizi, Sarah J.; Rees, Geraint; Langbehn, Douglas; Orth, Michael
Journal:
Human brain mapping
Issue:
Volume 39:Issue 9(2018)
Page Start:
3516
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1–30 fragment. Issue 5 (June 2016)

Authors:
Wagner, Leona; Björkqvist, Maria; Lundh, Sofia Hult; Wolf, Raik; Börgel, Arne; Schlenzig, Dagmar; Ludwig, Hans‐Henning; Rahfeld, Jens‐Ulrich; Leavitt, Blair; Demuth, Hans‐Ulrich; Petersén, Åsa; von Hörsten, Stephan
Journal:
Journal of neurochemistry
Issue:
Volume 137:Issue 5(2016)
Page Start:
820
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗